Login / Signup

The ERA Registry Annual Report 2020: a summary.

Megan E AstleyRianne BoeninkSamar Abd ElHafeezSara Trujillo-AlemánFederico ArribasAnders ÅsbergPazit BeckermanSamira BellMaría Encarnación Bouzas-CaamañoJordi Comas FarnésAna Amélia GalvãoNikola GjorgjievskiVjollca Godanci KelmendiRebecca GuidottiJaakko HelveAlma IdriziÓlafur S IndriðasonKyriakos IoannouJulia KerschbaumKirill KomissarovPablo Castro de la NuezMathilde LassalleMaurizio NordioOlga Lucía Rodríguez ArévaloCarmen SantiusteNurhan SeyahiMaría Fernanda Slon RobleroRetha SteenkampMarc A G J Ten DamElena V ZakharovaEdita ZiginskieneMarjolein BonthuisVianda S StelAlberto OrtizKitty J JagerAnneke Kramer
Published in: Clinical kidney journal (2023)
A general population of 654.9 million people was covered by the ERA Registry in 2020. The overall incidence of KRT was 128 per million population (p.m.p.). In incident KRT patients, 54% were older than 65 years, 63% were men and the most common PRD was diabetes mellitus (21%). Regarding initial treatment modality in incident patients, 85% received haemodialysis (HD), 11% received peritoneal dialysis (PD) and 4% received a pre-emptive kidney transplant. On 31 December 2020, the prevalence of KRT was 931 p.m.p. In prevalent patients, 45% were older than 65 years, 60% were men and glomerulonephritis was the most common PRD (18%). Of these patients, 58% were on HD, 5% on PD and 37% were living with a kidney transplant. The overall kidney transplantation rate in 2020 was 28 p.m.p., with a majority of kidney grafts from deceased donors (71%). The unadjusted 5-year survival, based on incident dialysis patient from 2011-15, was 41.8%. For patients having received a deceased donor transplant, the unadjusted 5-year survival probability was 86.2% and for patients having received a living donor transplant it was 94.4%. When comparing data by PRD group, differences were found regarding the distribution of age groups, sex and treatment modality received.
Keyphrases